Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation
Medgadget
MARCH 2, 2023
Special software that takes DICOM images from CT scanners and creates a treatment plan, defines the distribution of the Alpha DaRT sources within the tumor. The FDA looked at the data, saw it promising, and asked for a small feasibility study in the U.S. In the first study there was a 78% complete response (no residual cancer).
83 
Let's personalize your content